Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: Perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor

Journal of Immunology

Volumn 161, Issue 1, 1998, Pages 342-346

  Fioretti, Francesca ^a   Fradelizi, Didier ^b   Stoppacciaro, Antonella ^c   Ramponi, Simona ^a   Ruco, Luigi ^c   Minty, Adrian ^d   Sozzani, Silvano ^a   Garlanda, Cecilia ^a   Vecchi, Annunciata ^a   Mantovani, Alberto ^a,e,f  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Inst Natl de la S et de la R ^*  (France)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d SANOFI   (France)

^e UNIVERSITY OF BRESCIA   (Italy)

^f Ist Ric Farmacologiche Mario Negri ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 3;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARCINOGENICITY; CELL INFILTRATION; CELL MEDIATED CYTOTOXICITY; DENDRITIC CELL; EOSINOPHIL; GENE TRANSFER; LYMPHOCYTE ACTIVATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; T LYMPHOCYTE; TUMOR REJECTION;

ANIMALS; CELL MOVEMENT; CYTOKINES; DENDRITIC CELLS; GENE TRANSFER TECHNIQUES; GRAFT REJECTION; IMMUNITY, NATURAL; LEUKOCYTES; MALE; MAST-CELL SARCOMA; MICE; MICE, INBRED DBA; MICE, NUDE; MONOCYTE CHEMOATTRACTANT PROTEINS; NEOPLASM TRANSPLANTATION; NEUTROPHILS; TRANSFECTION;

EID: 7144253145     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Musiani, P., A. Modesti, M. Giovarelli, F. Cavallo, M. P. Colombo, P. L. Lollini, and G. Forni. 1997. Cytokines, tumor-cell death and immunogenicity: a question of choice. Immunol. Today 18:32.
2. Pardoll, D. M. 1995. Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol. 13:399.
3. Hock, H., M. Dorsch, U. Kunzendorf, Z. Qin, T. Diamantstein, and T. Blankenstein. 1993. Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma. Proc. Natl. Acad. Sci. USA 90:2774.
4. Baggiolini, M., B. Dewald, and B. Moser. 1994. lnterleukin-8 and related chemotactic cytokines - CXC and CC chemokines. Adv. Immunol. 55:99.
5. Negus, R. P., G. W. Stamp, M. G. Relf, F. Burke, S. T. Malik, S. Bernasconi, P. Allavena, S. Sozzani, A. Mantovani, and F. R. Balkwill. 1995. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J. Clin. Invest. 95:2391.
6. Sciacca, F. L., M. Stürzl, F. Bussolino, M. Sironi, H. Brandstetter, C. Zietz, D. Zhou, C. Matteucci, G. Peri, S. Sozzani, R. Benelli, M. Arese, A. Albini, F. Colotta, and A. Mantovani. 1994. Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells. J. Immunol. 153:4816.
7. Riethdorf, L., S. Riethdorf, K. Gutzlaff, F. Prall, and T. Loning. 1996. Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri. Am. J. Pathol. 149:1469.
8. Graves, D. T., R. Barnhill, T. Galanopoulos, and H. N. Antoniades. 1992. Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am. J. Pathol. 140:9.
9. Angiolillo, A. L., C. Sgadari, D. D. Taub, F. Liao, J. M. Farber, S. Maheshwari, H. K. Kleinman, G. H. Reaman, and G. Tosato. 1995. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182:155.
10. Luster, A. D., and P. Leder. 1993. 1P-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo. J. Exp. Med. 178:1057.
11. Hirose, K., M. Hakozaki, Y. Nyunoya, Y. Kobayashi, K. Matsushita, T. Takenouchi, A. Mikata, N. Mukaida, and K. Matsushima. 1995. Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration. Br. J. Cancer 72:708.
12. Rollins, B. J., and M. E. Sunday. 1991. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol. Cell Biol. 11:3125.
13. Bottazzi, B., S. Walter, D. Govoni, F. Colotta, and A. Mantovani. 1992. Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J. Immunol. 148:1280.
14. Walter, S., B. Bottazzi, D. Govoni, F. Colotta, and A. Mantovani. 1991. Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein/JE. Int. J. Cancer 49:431.
15. Mulé, J. J., M. Custer, B. Averbook, J. C. Yang, J. S. Weber, D. V. Goeddel, S. A. Rosenberg, and T. J. Schall. 1996. RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: role of immune cell subpopulations. Hum. Gene Ther. 7:1545.
16. Dilloo, D., K. Bacon, W. Holden, W. Y. Zhong, S. Burdach, A. Zlotnik, and M. Brenner. 1996. Combined chemokine and cytokine gene transfer enhances antitumor immunity. Nat. Med. 2:1090.
17. Mantovani, A., B. Bottazzi, S. Sozzani, G. Peri, P. Allavena, Q. G. Dong, A. Vecchi, and F. Colotta. 1993. Cytokine regulation of tumour-associated macrophages. Res. Immunol. 144:280.
18. Sozzani, S., F. Sallusto, W. Luini, D. Zhou, L. Piemonti, P. Allavena, J. Van Damme, S. Valitutti, A. Lanzavecchia, and A. Mantovani. 1995. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol. 155:3292.
19. Godiska, R., D. Chantry, C. J. Raport, S. Sozzani, P. Allavena, D. Leviten, A. Mantovani, and P. W. Gray. 1997. Human macrophage derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte derived dendritic cells, and natural killer cells. J. Exp. Med. 185:1595.
20. Sozzani, S., W. Luini, A. Borsatti, N. Polentarutti, D. Zhou, L. Piemonti, G. D'Amico, C. A. Power, T. N. Wells, M. Gobbi, P. Allavena, and A. Mantovani. 1997. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J. Immunol. 159:1993.
21. Xu, L. L., M. K. Warren, W. L. Rose, W. H. Gong, and J. M. Wang. 1996. Human recombinant monocyte chemotactic protein and other c- c chemokines bind and induce directional migration of dendritic cells in vitro. J. Leukocyte Biol. 60:365.
22. Morelli, A., A. Larregina, E. Chuluyan, E. Kolkowski and L. Fainboim. 1996. Expression and modulation of C5a receptor (CD88) on skin dendritic cells. Chemotactic effect of C5a on skin migratory dendritic cells. Immunology 89:126.
23. Paglia, P., C. Chiodoni, M. Rodolfo, and M. P. Colombo. 1996. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183:317.
24. Celluzzi, C. M., J. I. Mayordomo, W. J. Storkus, M. T. Lotze, and L. D. Falo. 1996. Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J. Exp. Med. 183:283.
25. Zitvogel, L., J. I. Mayordomo, T. Tjandrawan, A. B. Deleo, M. R. Clarke, M. T. Lotze, and W. J. Storkus. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J. Exp. Med. 183:87.
26. Van Damme, J., P. Proost, J. P. Lenaerts, and G. Opdenakker. 1992. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J. Exp. Med. 176:59.
27. Minty, A., P. Chalon, J. C. Guillemot, M. Kaghad, P. Liauzun, M. Magazin, B. Miloux, C. Minty, P. Ramond, N. Vita, J. Lupker, D. Shire, P. Ferrara, and D. Caput. 1993. Molecular cloning of the MCP-3 chemokine gene and regulation of its expression. Eur. Cytokine Netw. 4:99.
28. Sozzani, S., D. Zhou, M. Locati, M. Rieppi, P. Proost, M. Magazin, N. Vita, J. Van Damme, and A. Mantovani. 1994. Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3: similarities and differences with MCP-1. J. Immunol. 152:3615.
29. Neote, K., D. DiGregorio, J. Y. Mak, R. Horuk, and T. J. Schall. 1993. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 72:415.
30. Gao, J. L., D. B. Kuhns, H. L. Tiffany, D. McDermott, X. Li, U. Francke, and P. M. Murphy. 1993. Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor. J. Exp. Med. 177:1421.
31. Xu, L. L., D. W. McVicar, A. Ben-Baruch, D. B. Kuhns, J. Johnston, J. J. Oppenheim, and J. M. Wang. 1995. Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors: binding and signaling of MCP3 through shared as well as unique receptors on monocytes and neutrophils. Eur. J. Immunol. 25:2612.
32. Ponath, P. D., S. X. Qin, T. W. Post, J. Wang, L. Wu, N. P. Gerard, W. Newman, C. Gerard, and C. R. Mackay. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183:2437.
33. Loetscher, P., M. Seitz, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1994. Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4(+) and CD8(+) T lymphocytes. FASEB J. 8:1055.
34. Taub, D. D., P. Proost, W. J. Murphy, M. Anver, D. L. Longo, J. Van Damme, and J. J. Oppenheim. 1995. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J. Clin. Invest. 95:1370.
35. Allavena, P., G. Bianchi, D. Zhou, J. Van Damme, P. Jilek, S. Sozzani, and A. Mantovani. 1994. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur. J. Immnnol. 24:3233.
36. Dahinden, C. A., T. Geiser, T. Brunner, V. von Tschamer, D. Caput, P. Ferrara, A. Minty, and M. Baggiolini. 1994. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J. Exp. Med. 179:751.
37. Stoppacciaro, A., C. Melani, M. Parenza, A. Mastracchio, C. Bassi, C. Baroni, G. Parmiani, and M. P. Colombo. 1993. Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma. J. Exp. Med. 178:151.
38. Ping, D. S., P. L. Jones, and J. M. Boss. 1996. TNF regulates the in vivo occupancy of both distal and proximal regulatory regions of the MCP-1/JE gene. Immunity 4:455.
39. Vecchi, A., C. Garlanda, M. G. Lampugnani, M. Resnati, C. Matteucci, A. Stoppacciaro, H. Schnurch, W. Risau, L. Ruco, A. Mantovani, and E. Dejana. 1994. Monoclonal antibodies specific for endothelial cells of mouse blood vessels: their application in the identification of adult and embryonic endothelium. Eur. J. Cell Biol. 63:247.
40. Franci, C., L. M. Wong, J. Van Damme, P. Proost, and I. F. Charo. 1995. Monocyte chemoattractant protein-3, but not monocyte chemoattractant protein-2, is a functional ligand of the human monocyte chemoattractant protein-1 receptor. J. Immunol. 154:6511.
41. Ben-Baruch, A., L. Xu, P. R. Young, K. Bengali, J. J. Oppenheim, and J. M. Wang. 1995. Monocyte chemotactic protein-3 (MCP-3) interacts with multiple leukocyte receptors. J. Biol. Chem. 270:22123.
42. Noso, N., P. Proost, J. Van Damme, and J. M. Schroder. 1994. Human monocyte chemotactic proteins-2 and 3 (MCP-2 and MCP- 3) attract human eosinophils and desensitize the chemotactic responses towards RANTES. Biochem. Biophys. Res. Commun. 200:1470.
43. Polentarutti, N., P. Allavena, G. Bianchi, G. Giardina, A. Basile, S. Sozzani, A. Mantovani, and M. Introna. 1997. IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-Kb transcript containing CCR2B and CCR2A sequences. J. Immunol. 158:2689.
44. Loetscher, P., M. Seitz, M. Baggiolini, and B. Moser. 1996. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 184:569.
45. Ruco, L. 1994. Tumor-infiltrating leukocytes: histology, immunohistochemistry and in situ hybridization. In Tumor-Associated Leukocytes: Pathophysiology and Therapeutic Applications, A. Mantovani, ed. R. G. Landes Co., Austin, TX, p. 15.
46. Colombo, M. P., L. Lombardi, A. Stoppacciaro, C. Melani, M. Parenza, B. Bottazzi, and G. Parmiani. 1992. Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. J. Immunol 149:113.
47. Van den Eynde, B., B. Lethé, A. Van Pel, E. De Plaen, and T. Boon. 1991. The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J. Exp. Med. 173:1373.